Litcius/Paper detail

Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma

Jutatip Panaampon, Ryusho Kariya, Seiji Okada

2021Cancer Immunology Immunotherapy16 citationsDOIOpen Access PDF

Topics & Concepts

DaratumumabAntibody-dependent cell-mediated cytotoxicityPrimary effusion lymphomaCancer researchMonoclonal antibodyAntibodyLymphomaImmunologyMedicineImmune Cell Function and InteractionChronic Lymphocytic Leukemia ResearchCalcium signaling and nucleotide metabolism
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma | Litcius